News

STALICLA announces closure of CHF 10 million total for first tranche of series A

STALICLA is pleased to announce the successful closure of the 2018 tranche of its series A round for a total amount of CHF 10M committed by a consortium of private and Biotech experienced investors

Read more

STALICLA CEO, Lynn Durham presents STALICLA’s most recent biomarker data at the 2nd Annual Neuroscience Innovation Forum in San Francisco

STALICLA CEO, Lynn Durham presents STALICLA’s most recent biomarker data at the 2nd Annual Neuroscience Innovation Forum in San Francisco

Read more

Interview of STALICLA’s CEO and Founder, Lynn DURHAM, on CNN Money.ch

STALICLA’s CEO & founder’s interview on CNN money.ch from November 21st is available to stream online:

Read more

Search for content on Stalicla...